0001104659-24-084916.txt : 20240801
0001104659-24-084916.hdr.sgml : 20240801
20240801161822
ACCESSION NUMBER: 0001104659-24-084916
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240801
FILED AS OF DATE: 20240801
DATE AS OF CHANGE: 20240801
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Benesch Joseph
CENTRAL INDEX KEY: 0001887515
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41063
FILM NUMBER: 241166984
MAIL ADDRESS:
STREET 1: C/O TELIGENT
STREET 2: 105 LINCOLN AVENUE
CITY: BUENA
STATE: NJ
ZIP: 08310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Journey Medical Corp
CENTRAL INDEX KEY: 0001867066
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 471879539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9237 E VIA DE VENTURA BLVD., SUITE 105
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
BUSINESS PHONE: 480-434-6670
MAIL ADDRESS:
STREET 1: 9237 E VIA DE VENTURA BLVD., SUITE 105
CITY: SCOTTSDALE
STATE: AZ
ZIP: 85258
4
1
tm2420691-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-08-01
0
0001867066
Journey Medical Corp
DERM
0001887515
Benesch Joseph
C/O JOURNEY MEDICAL CORPORATION
9237 E VIA DE VENTURA BLVD., SUITE 105
SCOTTSDALE
AZ
85258
0
1
0
0
CFO
0
Common Stock, $0.0001 par value
2024-08-01
4
S
0
9324
5.47
D
47331
D
In connection with the vesting of restricted stock units on July 31, 2024, a total of 9,324 of such underlying shares were sold by the Issuer in order to satisfy the Reporting Person's tax withholding obligations. The Reporting Person had no discretion with respect to such sale, which was conducted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock units.
Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on August 1, 2024, was $5.45 to $5.55. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.
Includes restricted stock units, which vest over various time periods
/s/ Ramsey Alloush, attorney-in-fact
2024-08-01